| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:125.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology and To-icology, Michigan State University, East Lansing.
Correspondence to Carrie A. Northcott, PhD, Department of Pharmacology and To-icology, Michigan State University, B445 Life Science Bldg, East Lansing, MI 48823. E-mail taetscar @msu.edu
| Abstract |
|---|
|
|
|---|
Key Words: magnesium kinase deoxycorticosterone hypertension, sodium-dependent phosphorylation
| Introduction |
|---|
|
|
|---|
-nitro-L-arginine hypertensive rats.1 PI3K activity and protein, specifically the p110
class IA PI3K catalytic subunit, is upregulated in the aorta in experimental hypertension.1 PI3K catalytic subunits can directly associate with L-type Ca2+ channels and increase Ca2+ current to the cell.2,3 Moreover, Ca2+-induced spontaneous tone in aortas from DOCA-salt rats is dependent on PI3K.1 However, it is unclear what stimulates the increase in PI3K activity in the condition of hypertension. Mg2+ deficiency is found in hypertension and is also a mechanism suggested to activate a PI3K-dependent signaling pathway.46 Thus, altered Mg2+ might be one explanation for the increase in PI3K observed in hypertension. Mg2+ is a mineral required by every cell of the body and is necessary for g300 biochemical reactions, including maintenance of normal muscle and nerve function, heart rhythm, energy metabolism, and protein synthesis.79 Intracellular Mg2+ concentration ( [Mg2+]i) regulates contractile proteins; modulates transmembrane transport of calcium, sodium, and potassium; acts as a essential cofactor in activation of ATPases; and influences DNA and protein synthesis.911 Mg2+ concentrations are inversely proportional to blood pressure, with hypomagnesemia associated with hypertension.7,911 Mg2+ deficiency induces cardiovascular alterations such as elevated blood pressure, enhanced agonist-mediated reactivity, attenuated responses to vasodilators, and increased vascular tone.9,10,12,13 Serum and erythrocyte Mg2+ concentrations are lower in DOCA-salt spontaneously hypertensive rats (SHR) compared with SHR.14 [Mg2+]i is lower in vascular smooth muscle cells of SHR versus Wistar-Kyoto rats.11 In the experimental DOCA-salt rat model of hypertension, plasma total and free Mg2+ concentrations are significantly lower compared with sham.15 This study is in contrast to a previous report of similar serum Mg2+ concentrations in DOCA-salt and sham rats.16 The differences in measurements of Mg2+ might be due to the technique by which Mg2+ was measured, a debate that is also found in measurement of Mg2+ levels in humans. Nonetheless, multiple investigators have found that dietary Mg2+ supplementation attenuates hypertension in the DOCA-salt rat model of hypertension.1518 Low Mg2+ utilization/activation of Ca2+, Na+/K+-ATPase, tyrosine kinases, protein kinase C, and mitogen-activated protein kinase components have been implicated in altered vascular tone and/or cellular growth.4,5,9,10,1924 If Mg2+ is a modulator of PI3K, then low Mg2+ might be one mechanism that amplifies PI3K activity. Thus, we hypothesized that a decrease in Mg2+, a tool for activation of the PI3K signaling cascade, elicits enhanced vascular contraction represented by spontaneous tone development and enhanced norepinephrine (NE)-induced contraction in the aorta.
| Methods |
|---|
|
|
|---|
Isolated Tissue Bath Protocol
Thoracic aortas were removed from pentobarbital- (60 mg/kg IP) anesthetized rats, cut into helical strips, and denuded of endothelial cells with a moistened cotton swab. The strips were pair-mounted (sham/DOCA) in isolated tissue baths containing warmed (37°C), aerated (95 % O2/CO2) physiologic salt solution (PSS: 103 mmol/L NaCl, 4.7 mmol/L KCl, 1.18 mmol/L KH2PO4, 1.17 mmol/L MgSO4 · 7H2O, 1.6 mmol/L CaCl2 · 2H2O, 14.9 mmol/L NaHCO3, 5.5 mmol/L dextrose, and 0.03 mmol/L CaNa2 EDTA) for measurements of isometric force.25 Tissues were challenged with the
1-adrenergic agonist phenylephrine (PE, 1 x10-5 mol/L) to ensure arterial strip viability. Functional integrity of endothelial cells was evaluated by testing endothelium-dependent relaxation to acetylcholine (1 x10-6 mol/L) in half-maximal PE-contracted strips. Tissues were incubated in PSS buffer containing low extracellular Mg2+ concentration ( [Mg2+]e) (0.15 mmol/L), normal, or high [Mg2+]e (4.8 mmol/L) PSS for 30 minutes. The buffer was changed every 10 minutes to permit equilibration. After 30 minutes of incubation, changes in spontaneous tone were recorded in response to the respective changes in Mg2+. LY294002 (20 µmol/L, Biomol) or vehicle (0.1 % dimethyl sulfoxide) was incubated in the baths for 30 minutes before the addition of increasing concentrations of NE (1 x10-9 to 3 x10-6 mol/L).
PI3K Activity Assay
Rat thoracic aortas were cleaned and placed in isolated tissue baths, incubated in low [Mg2+]e and normal PSS for 30 minutes, allowed to develop tone as stated earlier, and then rozen in LN2. Aortas were pulverized in an LN2-cooled mortar and solubilized in PI3K lysis buffer (20 mmol/L Tris, pH 7.6; 10 % glycerol; 1 % NP-40; 140 mmol/L NaCl; 2.5 mmol/L CaCl2; 1 mmol/L MgCl2; 1 mmol/L Na3VO4; 1 mmol/L dithiothreitol; and 1 mmol/L phenylmethylsulfonyl fluoride). Equal amounts of protein were immunoprecipitated for PI3K with the antibody for the regulatory PI3K subunit p85
(5 µmL, Upstate Biotechnology) and protein Aagarose beads (70 µmL, Invitrogen). Northcott et al1 determined that p85
immunoprecipitates the p110
, p110ß, and p110
catalytic subunits. The PI3K assay was performed as previously described.1,26,27 The radioactive product corresponding to PI3-monophosphate was spotted by thin-layer chromatography and visualized with a Bio-Rad personal molecular imager FX system.
Data Analyses
Data are presented as mean +SEM. Potency values (-log EC50 in mol/L) were determined with GRAPHPAD Prism software. Spontaneous tone measurements are reported as percent initial PE (10-5 mol/L) contraction. NE-induced contractions are displayed as percent maximum NE-induced contraction to compensate for alterations in spontaneous tone. PI3-monophosphateradiolabeled areas were quantified with National Institutes of Health IMAGE software, version 1.61. When 2 groups were compared, a Student t test was used. For multiple comparisons, an ANOVA followed by least significant difference analysis and Student-Newman-Keuls post hoc tests was performed with SAS version 8.2 statistical software. In all cases, a value of P H0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
PI3K Activity Assays
PI3K activity assays were performed to determine whether the increase in low [Mg2+]einduced spontaneous tone that was LY294002- and thus, likely PI3K-dependent, was reflected biochemically. In aortic samples exposed to PSS in the tissue bath, there was a trend, but no significant difference, for the increase in PI3K activity in aortas from DOCA-salt and sham rats incubated in PSS (Figure 3A, compare shaded bars and Figure 3B, compare radiolabeled PI3-monophosphate in first and third lanes). When aortic strips were incubated in low Mg2+, there was also a trend for an increase in PI3K activity, albeit neither were statistically significant (Figure 3A and 3B).
|
NE-Induced Contraction
We last examined the effects of low [Mg2+]e on NE-induced contraction. Low [Mg2+]e significantly leftward-shifted NE-induced contraction in aortas from the sham rats. The NE-induced contraction in aortas from sham rats in low [Mg2+]e was similar to that of the DOCA-salt rats incubated in either PSS or low Mg2+. No further shift occurred in aortas from DOCA-salt rats when exposed to low [Mg2+]e (Figure 4A). LY294002 (20 µmol/L) shifted the NE-induced aortic contraction of both the sham and DOCA-salt rats in the presence of low Mg2+ compared with vehicle, resulting in similar potencies (Figure 4B). When the LY294002-mediated inhibition of NE-induced contraction in aortas from sham and DOCA-salt rats was compared, there was no significant difference between the aortic strips incubated in normal PSS compared with low Mg2+ PSS (Figure 4C). Thus, low [Mg2+]e appears to elicit enhanced NE-induced contraction via PI3K in aortas from sham rats but not from DOCA-salt rats.
|
| Discussion |
|---|
|
|
|---|
[Mg2+]e eficiency, through Mg2+ removal, induces contraction of aortas from normotensive rats via the activation of mitogen-activated protein kinase, PI3K, and SH2 domaincontaining proteins.4,5 We determined that low [Mg2+]e, created experimentally, enhanced spontaneous tone in aortas from both sham and DOCA-salt rats. The PI3K inhibitor LY294002 abolished this spontaneous tone, linking low [Mg2+]e with PI3K and spontaneous tone. Mechanistically, PI3K can directly alter Ca2+ flux in rat portal vein myocytes and enhance spontaneous tone in a calcium-dependent manner in aortas from DOCA-salt ats.13 Reduction in [Mg2+]e results in a rapid concentration-dependent increase in [Ca2+]i in cerebral vascular smooth muscle cells. Moreover, low [Mg2+]e leads to an increase in c-fos and c-jun as well as an induction of the p65 subunit of nuclear factor
B in cerebral vascular smooth muscle cells.34 [Ca2+]i and Ca2+ uptake in DOCA-salttreated rats is inhibited when oral Mg2+ is given to DOCA-salt rats, suggesting a role for Mg2+ in the handling of Ca2+.17 When [Mg2+]e was removed from the medium, there was a significant increase in [Ca2+]i observed in smooth muscle cells isolated from rat aortas; however, incubation with LY294002 inhibited this rise in [Ca2+]i.16 Moreover, low [Mg2+]e initiated contraction in canine basilar arterial smooth muscle cells via Ca2+ influx through voltage-gated Ca2+ channels, intracellular Ca2+ release, and activation of protein kinase C and PI3K.6 These previous studies demonstrate the potential of low Mg2+ to influence arterial contraction in a PI3K-dependent manner, thus linking PI3K and calcium. Our studies add the connection of low [Mg2+]e activation of PI3K as being a potential cause of arterial spontaneous tone in hypertension, tone that is PI3K dependent. Thus, low Mg2+induced enhancement of spontaneous tone in aortas from DOCA-salt rats is likely due to PI3K stimulation, potentially through PI3K 's activating L-type Ca2+ channels and increasing [Ca2+]i. Conversely, high Mg2+ attenuated spontaneous tone in the aortas from DOCA-salt hypertensive rats, confirming other studies.13
PI3K activity is increased in aortas from hypertensive DOCA-salt rats compared with sham rats.1 If low [Mg2+]e activates PI3K in vascular smooth muscle, as LY294002-induced elimination of spontaneous tone suggests, PI3K activity should be increased in the smooth muscle of the aorta. When endothelium-denuded aortic strips from DOCA-salt and sham rats were placed in the tissue bath and incubated in normal PSS and low [Mg2+]e PSS, there was a trend for increases in PI3K activity caused by low Mg2+ stimulation of PI3K. These data do not quantitatively repeat earlier studies, in which there was statistically significantly higher PI3K activity in the DOCA-salt compared with sham rats.1 However, in the present experiment, several differences in protocol might account for our not observing a significant increase in PI3K activity, and these are all variables that might have masked and/or altered the magnitude of increase in PI3K activity: (1) tissues were incubated in altered salt conditions, (2) tension was pulled on the strips to achieve optimum length, (3) PI3K protein isolation buffer had Mg2+ present, and (4) more time elapsed until protein isolation. Nonetheless, there was a trend of increased activity in the arteries incubated in low Mg2+.
In summary, there was a small increase in spontaneous tone in aortas of the sham rats compared with a large increase observed in the aortas from DOCA-salt rats. Aortic strips incubated in low [Mg2+]e suggested a trend for increased activity in both sham and DOCA-salt rats. Taken together, these data suggest that although low Mg2+ levels can activate PI3K, PI3K is not the sole signal-transduction component that mediates spontaneous tone.
In DOCA-salt rats, Laurant et al18 determined that the blood pressurelowering effect of Mg2+ supplementation in DOCA-salt hypertension was associated with lower in vivo cardiovascular reactivity to NE and angiotensin II. DiPette et al16 found no decrease in plasma Mg2+ concentration but did observe that Mg2+ supplementation reduced blood pressure, leading to the hypothesis of altered Mg2+ sensitivity in arteries. Other studies have shown that low [Mg2+]e potentiated NE-induced vasoconstriction in mesenteric arteries from SHR but not Wistar-Kyoto rats and altered vasopressin-induced vascular contraction; high [Mg2+]e attenuated both vasopressin- and NE-induced vasoconstriction.12 Our studies demonstrated hyperreactivity to NE-induced contraction in aortas from sham rats incubated in low Mg2+ PSS, resulting in similar potency of aortas from DOCA-salt rats. However, in aortas from DOCA-salt rats, there was no further hyperreactivity to NE-induced contraction. LY294002 normalized the NE-induced enhanced contraction in all aortic strips. These data further support the idea that PI3K is responsible for enhanced NE-induced contraction, similar to previous studies, and that PI3K mediates the enhanced NE-induced contraction in the presence of low [Mg2+]e.1 he lack of a further leftward shift in NE-induced contraction in aortas from DOCA-salt rats by low [Mg2+]e indicates that more than PI3K must be stimulated to further shift the contraction in the aortas or that NE-induced activation of PI3K in the DOCA-salt rats is already maximal, and NE, unlike spontaneous tone, might depend on PI3K activity to a lesser degree.
Perspectives
The cellular mechanisms by which [Mg2+]e deficiencyinduced enhanced hyperreactivity occurs has been extensively studied in multiple experimental models and clinical settings yet has not been fully elucidated. Increases in spontaneous tone and enhanced NE-induced contraction are 2 vascular dysfunctions observed in hypertension, as well as under conditions of low [Mg2+]e. Previous studies in our laboratory have demonstrated that there is a functional increase in PI3K dependentinduced spontaneous tone and NE-induced reactivity in DOCA-salt and N
-nitro-L-arginine rat models of hypertension.1 The current studies demonstrate that low [Mg2+]e might be one nonreceptor-dependent mechanism by which PI3K activity is increased in the condition of hypertension, leading to vascular dysfunction by altering arterial spontaneous tone and NE-induced contraction. Multiple studies have also examined the role of Mg2+ supplementation experimentally as well as clinically in correcting and/or treating high blood pressure but thus far, have not clearly determined whether Mg2+ supplementation has any beneficial effects. Further studies addressing whether Mg2+ supplementation will revert signaling pathways upregulated in hypertension back to "normal" would be useful. Limitations of the present and other studies are that we have no knowledge of the real cause and effect of alterations in Mg2+ concentrations in terms of hypertension and the vasculature, nor do we define the exact mechanism by which [Mg2+]e alters PI3K-dependent tone or interacts with Ca2+ channels. However, these studies do further our knowledge, in that low [Mg2+]e can cause LY294002- and thus, PI3K-dependent alterations in arterial contraction.
| Acknowledgments |
|---|
Received August 8, 2003; first decision August 29, 2003; accepted October 16, 2003.
| References |
|---|
|
|
|---|
2. Macrez N, Minornneau C, Carricaburu V, Quignard JF, Babich A, Czupalla C, Nurnberg B, Miranneau J. Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca2+ channels. Circ Res. 2001; 89: 692699.
3. Viard P, Exner T, Maier U, Mironneau J, Nurnberg B, Macrez N. Gß
dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase. FASEB J. 1999; 13: 685694.
4. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Importance of PKC and PI3Ks in ethanol-induced contraction of cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2001; 280: H2144H2152.
5. Yang Z, Wang J, Altura BT, Altura BM. Extracellular magnesium deficiency induces contraction of arterial muscle: role of PI3-kinases and MAPK signaling pathways. Pflugers Arch. 2000; 439: 240247.[CrossRef][Medline] [Order article via Infotrieve]
6. Yang Z, Wang J, Zheng T, Altura BT, Altura BM. Low [Mg2+]o induces contraction and [Ca2+]I rises in cerebral arteries: roles of Ca2+, PKC, and PI3. Am J Physiol Heart Circ Physiol. 2000; 279: H2898H2907.
7. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001; 56: 163170.[Medline] [Order article via Infotrieve]
8. Facts About Dietary Supplements. Clinical Nutrition Service, Warren Grant Magnuson Clinical Center, Office of Dietary Supplements, National Institutes of Health. Washington, DC: National Institutes of Health; March 2001.
9. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003; 24: 107136.[CrossRef][Medline] [Order article via Infotrieve]
10. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens. 2000; 18: 11771191.[CrossRef][Medline] [Order article via Infotrieve]
11. Rusch NJ, Kotchen TA. Vascular smooth muscle regulation by calcium, magnesium and potassium in hypertension. In: Swales JD, ed. Textbook of Hypertension. Oxford, England: Blackwell Scientific Publishers; 1994: 188199.
12. Laurant P, Touyz RM, Schiffrin EL. Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats. Can J Physiol Pharmacol. 1997; 75: 293300.[CrossRef][Medline] [Order article via Infotrieve]
13. Laurant P, Berthelot A. Influence of endothelium in the in vitro vasorelaxant effect of magnesium on aortic basal tension in DOCA-salt hypertensive rat. Magnes Res. 1992; 5: 255260.[Medline] [Order article via Infotrieve]
14. Touyz RM, Marshall PR, Milne FJ. Altered cations and muscle membrane ATPase activity in deoxycorticosterone acetate-salt spontaneously hypertensive rats. J Hypertens. 1991; 9: 737750.[CrossRef][Medline] [Order article via Infotrieve]
15. Berthon N, Laurant P, Fellmann D, Berthelot A. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol. 2003; 42: 2431.[CrossRef][Medline] [Order article via Infotrieve]
16. DiPette DJ, Simpson K, Guntupalli J. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state. Magnesium. 1987; 6: 136149.[Medline] [Order article via Infotrieve]
17. Kh R, Khullar M, Kashyap M, Pandhi P, Uppal R. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deo-ycorticosterone acetate induced hypertension in rats. J Hypertens. 2000; 18: 919926.[CrossRef][Medline] [Order article via Infotrieve]
18. Laurant P, Kantelip JP, Berthelot A. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats. J Nutr. 1995; 125: 830841.
19. Yang Z, Wang J, Zheng T, Altura BT, Altura BM. Low [Mg2+]o induces contraction of cerebral arteries: roles of tyrosine and mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol. 2000; 279: H185H194.
20. Zheng T, Li W, Altura BT, Altura BM. Use of protein kinase C inhibitors results in rapid [Mg2+]i mobilization in primary cultured rat aortic smooth muscle cells: are certain kinase C isoforms natural homeostatic regulators of cystolic free Mg2+? Eur J Pharmacol. 2001; 413: R1R3.[CrossRef][Medline] [Order article via Infotrieve]
21. Wei SK, Quigley JF, Hanlon SU, O'Rourke B, Haigney MC. Cytosolic free magnesium modulates Na/Ca e-change currents in pig myocytes. Cardiovasc Res. 2002; 53: 334340.
22. Bara M, Guiet-Bara A. Magnesium regulation of Ca2+ channels in smooth muscle and endothelial cells of human allantochorial placental vessels. Magnes Res. 2001; 14: 1118.[Medline] [Order article via Infotrieve]
23. Altura BM, Zhang A, Cheng TP, Altura BT. E-tracellular magnesium regulates nuclear and perinuclear free ionized calcium in cerebral vascular smooth muscle cells: possible relation to alcohol and central nervous system injury. Alcohol. 2001; 23: 8390.[CrossRef][Medline] [Order article via Infotrieve]
24. Touyz RM, Laurant P, Schiffrin EL. Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. J Pharmacol E-p Ther. 1998; 284: 9981005.
25. Florian JA, Watts SW. Epidermal growth factor: a potent vasoconstrictor in e-perimental hypertension. Am J Physiol. 1999; 276: H976H983.[Medline] [Order article via Infotrieve]
26. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest. 2000; 105: 199205.[Medline] [Order article via Infotrieve]
27. Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem. 2002; 277: 10761084.
28. Saito N, Abbu GC, Konishi Y, Nishiyama S, Okada T. Magnesium, calcium and trace elements in spontaneously hypertensive rats. Clin E-p Pharmacol Physiol Suppl. 1995; 22: S212S214.
29. Wells IC, Agrawal DK. Abnormal magnesium metabolism in two rat models of genetic hypertension. Can J Physiol Pharmacol. 1992; 70: 12251229.[Medline] [Order article via Infotrieve]
30. Sasaki S, Oshima T, Matsuura H, Ozono R, Higashi Y, Saski N, Matsumoto T, Nakano Y, Ueda A, Yoshimizu A, Kurisu S, Kambe M, Kajiyama G. Abnormal magnesium status in patients with cardiovascular diseases. Clin Sci. 2000; 98: 175181.[Medline] [Order article via Infotrieve]
31. Fo- C, Ramsoomair D, Carter C. Magnesium: its proven and potential clinical significance. South Med J. 2001; 94: 11951201.[Medline] [Order article via Infotrieve]
32. Resnick LM, Bardicef O, Altura BT, Alderman MH, Altura BM. Serum ionized magnesium: relation to blood pressure and racial factors. Am J Hypertens. 1997; 10: 14201424.[Medline] [Order article via Infotrieve]
33. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci U tS tA. 1984; 81: 65116515.
34. Altura BM, Kostellow AB, Zhang A, Wenyan L, Morrill GA, Gupta RK, Altura BT. E-pression of the nuclear factor-
B and proto-oncogenes c-fos and c-jun are induced by low e-tracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke. Am J Hypertens. 2003; 16: 701707.[CrossRef][Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. M. Touyz Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1103 - H1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Clarke, V. Ohanian, and J. Ohanian Norepinephrine and endothelin activate diacylglycerol kinases in caveolae/rafts of rat mesenteric arteries: agonist-specific role of PI3-kinase Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2248 - H2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, Y. He, A. C. I. Montezano, G. Yao, V. Chubanov, T. Gudermann, and G. E. Callera Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R73 - R78. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, G. Yao, C. Savoia, and R. M. Touyz Transient Receptor Potential Melastatin 7 Ion Channels Regulate Magnesium Homeostasis in Vascular Smooth Muscle Cells: Role of Angiotensin II Circ. Res., February 4, 2005; 96(2): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |